nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ABCG2—Dactinomycin—germ cell cancer	0.0769	0.148	CbGbCtD
Gefitinib—CYP3A5—Ifosfamide—germ cell cancer	0.0503	0.0966	CbGbCtD
Gefitinib—ABCG2—Cisplatin—germ cell cancer	0.0442	0.0848	CbGbCtD
Gefitinib—ABCG2—Etoposide—germ cell cancer	0.0434	0.0833	CbGbCtD
Gefitinib—CYP2C19—Ifosfamide—germ cell cancer	0.0406	0.0779	CbGbCtD
Gefitinib—CYP2C9—Ifosfamide—germ cell cancer	0.0338	0.0648	CbGbCtD
Gefitinib—ABCG2—Methotrexate—germ cell cancer	0.0287	0.0551	CbGbCtD
Gefitinib—ABCB1—Dactinomycin—germ cell cancer	0.0277	0.0532	CbGbCtD
Gefitinib—CYP3A5—Etoposide—germ cell cancer	0.0241	0.0462	CbGbCtD
Gefitinib—ALB—Methotrexate—germ cell cancer	0.0198	0.038	CbGbCtD
Gefitinib—CYP3A4—Ifosfamide—germ cell cancer	0.0196	0.0377	CbGbCtD
Gefitinib—ABCB1—Vinblastine—germ cell cancer	0.0174	0.0334	CbGbCtD
Gefitinib—CYP2C9—Cisplatin—germ cell cancer	0.0164	0.0315	CbGbCtD
Gefitinib—CYP2D6—Vinblastine—germ cell cancer	0.0164	0.0314	CbGbCtD
Gefitinib—ABCB1—Cisplatin—germ cell cancer	0.0159	0.0306	CbGbCtD
Gefitinib—ABCB1—Etoposide—germ cell cancer	0.0157	0.03	CbGbCtD
Gefitinib—CYP3A4—Vinblastine—germ cell cancer	0.0104	0.02	CbGbCtD
Gefitinib—ABCB1—Methotrexate—germ cell cancer	0.0103	0.0199	CbGbCtD
Gefitinib—CYP3A4—Etoposide—germ cell cancer	0.00938	0.018	CbGbCtD
Gefitinib—CYP2C9—cardial valve—germ cell cancer	0.00563	0.0359	CbGeAlD
Gefitinib—SBK1—trigeminal ganglion—germ cell cancer	0.00248	0.0159	CbGeAlD
Gefitinib—SBK1—eye—germ cell cancer	0.00214	0.0137	CbGeAlD
Gefitinib—SBK1—retina—germ cell cancer	0.00212	0.0135	CbGeAlD
Gefitinib—CHEK2—decidua—germ cell cancer	0.00161	0.0103	CbGeAlD
Gefitinib—HIPK4—gonad—germ cell cancer	0.00161	0.0103	CbGeAlD
Gefitinib—SBK1—pituitary gland—germ cell cancer	0.00159	0.0101	CbGeAlD
Gefitinib—CHEK2—Vindesine—Vinblastine—germ cell cancer	0.00158	0.229	CbGdCrCtD
Gefitinib—CYP2C19—urine—germ cell cancer	0.00157	0.01	CbGeAlD
Gefitinib—SBK1—medulla oblongata—germ cell cancer	0.00153	0.00979	CbGeAlD
Gefitinib—ERBB3—Podofilox—Etoposide—germ cell cancer	0.00148	0.214	CbGdCrCtD
Gefitinib—SBK1—midbrain—germ cell cancer	0.0014	0.00895	CbGeAlD
Gefitinib—CHEK2—pituitary gland—germ cell cancer	0.00138	0.00884	CbGeAlD
Gefitinib—CSNK1E—trigeminal ganglion—germ cell cancer	0.00137	0.00876	CbGeAlD
Gefitinib—SBK1—spinal cord—germ cell cancer	0.00137	0.00873	CbGeAlD
Gefitinib—IRAK4—trigeminal ganglion—germ cell cancer	0.00135	0.00862	CbGeAlD
Gefitinib—ERBB3—embryo—germ cell cancer	0.00128	0.00816	CbGeAlD
Gefitinib—EPHA6—gonad—germ cell cancer	0.00127	0.00812	CbGeAlD
Gefitinib—MKNK2—trigeminal ganglion—germ cell cancer	0.00126	0.00804	CbGeAlD
Gefitinib—MKNK1—trigeminal ganglion—germ cell cancer	0.00124	0.00794	CbGeAlD
Gefitinib—CHEK2—adrenal gland—germ cell cancer	0.00124	0.00789	CbGeAlD
Gefitinib—HIPK4—endocrine gland—germ cell cancer	0.00122	0.00777	CbGeAlD
Gefitinib—SBK1—head—germ cell cancer	0.00121	0.00776	CbGeAlD
Gefitinib—CYP2C9—urine—germ cell cancer	0.00121	0.00775	CbGeAlD
Gefitinib—CHEK2—bone marrow—germ cell cancer	0.0012	0.00764	CbGeAlD
Gefitinib—SBK1—testis—germ cell cancer	0.00117	0.00749	CbGeAlD
Gefitinib—CSNK1E—retina—germ cell cancer	0.00117	0.00748	CbGeAlD
Gefitinib—HIPK4—testis—germ cell cancer	0.00116	0.00741	CbGeAlD
Gefitinib—CHEK2—female gonad—germ cell cancer	0.00115	0.00736	CbGeAlD
Gefitinib—EGFR—telencephalon—germ cell cancer	0.00112	0.00716	CbGeAlD
Gefitinib—MKNK2—eye—germ cell cancer	0.00108	0.00693	CbGeAlD
Gefitinib—SBK1—cerebellum—germ cell cancer	0.00108	0.00692	CbGeAlD
Gefitinib—CSNK1E—telencephalon—germ cell cancer	0.00108	0.00688	CbGeAlD
Gefitinib—MKNK2—retina—germ cell cancer	0.00107	0.00686	CbGeAlD
Gefitinib—MKNK1—eye—germ cell cancer	0.00107	0.00684	CbGeAlD
Gefitinib—MKNK1—retina—germ cell cancer	0.00106	0.00678	CbGeAlD
Gefitinib—ERBB3—telencephalon—germ cell cancer	0.00104	0.00664	CbGeAlD
Gefitinib—CSNK1E—skin of body—germ cell cancer	0.00103	0.00657	CbGeAlD
Gefitinib—STK10—trigeminal ganglion—germ cell cancer	0.00102	0.00654	CbGeAlD
Gefitinib—CHEK2—testis—germ cell cancer	0.00102	0.00653	CbGeAlD
Gefitinib—CYP1A1—skin epidermis—germ cell cancer	0.00102	0.00652	CbGeAlD
Gefitinib—CSNK1E—decidua—germ cell cancer	0.00102	0.00652	CbGeAlD
Gefitinib—IRAK4—decidua—germ cell cancer	0.00101	0.00642	CbGeAlD
Gefitinib—CHEK2—Vinorelbine—Vinblastine—germ cell cancer	0.000998	0.145	CbGdCrCtD
Gefitinib—CHEK2—Teniposide—Etoposide—germ cell cancer	0.000997	0.144	CbGdCrCtD
Gefitinib—CHEK2—Podofilox—Etoposide—germ cell cancer	0.000997	0.144	CbGdCrCtD
Gefitinib—ERBB3—skin of body—germ cell cancer	0.000992	0.00634	CbGeAlD
Gefitinib—MKNK2—telencephalon—germ cell cancer	0.000989	0.00631	CbGeAlD
Gefitinib—IRAK1—telencephalon—germ cell cancer	0.000989	0.00631	CbGeAlD
Gefitinib—MKNK1—telencephalon—germ cell cancer	0.000976	0.00623	CbGeAlD
Gefitinib—EPHA6—endocrine gland—germ cell cancer	0.000962	0.00614	CbGeAlD
Gefitinib—EPHA6—head—germ cell cancer	0.000949	0.00606	CbGeAlD
Gefitinib—MKNK2—decidua—germ cell cancer	0.000937	0.00598	CbGeAlD
Gefitinib—IRAK1—decidua—germ cell cancer	0.000937	0.00598	CbGeAlD
Gefitinib—EGFR—uterus—germ cell cancer	0.000929	0.00593	CbGeAlD
Gefitinib—CYP3A4—urine—germ cell cancer	0.000925	0.00591	CbGeAlD
Gefitinib—MKNK1—decidua—germ cell cancer	0.000925	0.00591	CbGeAlD
Gefitinib—EPHA6—testis—germ cell cancer	0.000917	0.00586	CbGeAlD
Gefitinib—MAP2K5—trigeminal ganglion—germ cell cancer	0.000914	0.00584	CbGeAlD
Gefitinib—CYP2D6—urine—germ cell cancer	0.000911	0.00582	CbGeAlD
Gefitinib—CSNK1E—uterus—germ cell cancer	0.000893	0.0057	CbGeAlD
Gefitinib—SBK1—brain—germ cell cancer	0.00088	0.00562	CbGeAlD
Gefitinib—CSNK1E—pituitary gland—germ cell cancer	0.000877	0.0056	CbGeAlD
Gefitinib—HIPK4—brain—germ cell cancer	0.00087	0.00556	CbGeAlD
Gefitinib—IRAK4—pituitary gland—germ cell cancer	0.000864	0.00552	CbGeAlD
Gefitinib—MAP3K19—head—germ cell cancer	0.000863	0.00551	CbGeAlD
Gefitinib—ERBB3—uterus—germ cell cancer	0.000862	0.0055	CbGeAlD
Gefitinib—CHEK2—Vincristine—Vinblastine—germ cell cancer	0.000853	0.124	CbGdCrCtD
Gefitinib—SBK1—lymph node—germ cell cancer	0.000851	0.00543	CbGeAlD
Gefitinib—CSNK1E—medulla oblongata—germ cell cancer	0.000847	0.00541	CbGeAlD
Gefitinib—MAP3K19—testis—germ cell cancer	0.000833	0.00532	CbGeAlD
Gefitinib—IRAK4—medulla oblongata—germ cell cancer	0.000833	0.00532	CbGeAlD
Gefitinib—MKNK2—gonad—germ cell cancer	0.000825	0.00527	CbGeAlD
Gefitinib—MKNK2—uterus—germ cell cancer	0.00082	0.00523	CbGeAlD
Gefitinib—EGFR—adrenal gland—germ cell cancer	0.000815	0.0052	CbGeAlD
Gefitinib—MKNK1—gonad—germ cell cancer	0.000815	0.0052	CbGeAlD
Gefitinib—MAP2K5—brainstem—germ cell cancer	0.000809	0.00517	CbGeAlD
Gefitinib—MKNK2—pituitary gland—germ cell cancer	0.000805	0.00514	CbGeAlD
Gefitinib—MKNK1—pituitary gland—germ cell cancer	0.000795	0.00508	CbGeAlD
Gefitinib—CSNK1E—adrenal gland—germ cell cancer	0.000784	0.005	CbGeAlD
Gefitinib—MKNK2—medulla oblongata—germ cell cancer	0.000777	0.00496	CbGeAlD
Gefitinib—CSNK1E—midbrain—germ cell cancer	0.000774	0.00494	CbGeAlD
Gefitinib—IRAK4—adrenal gland—germ cell cancer	0.000772	0.00493	CbGeAlD
Gefitinib—MKNK1—medulla oblongata—germ cell cancer	0.000767	0.0049	CbGeAlD
Gefitinib—CHEK2—brain—germ cell cancer	0.000767	0.0049	CbGeAlD
Gefitinib—STK10—decidua—germ cell cancer	0.000762	0.00487	CbGeAlD
Gefitinib—EGFR—female gonad—germ cell cancer	0.00076	0.00485	CbGeAlD
Gefitinib—CSNK1E—spinal cord—germ cell cancer	0.000755	0.00482	CbGeAlD
Gefitinib—ERBB3—midbrain—germ cell cancer	0.000747	0.00477	CbGeAlD
Gefitinib—IRAK4—bone marrow—germ cell cancer	0.000746	0.00477	CbGeAlD
Gefitinib—IRAK4—spinal cord—germ cell cancer	0.000743	0.00475	CbGeAlD
Gefitinib—CHEK2—lymph node—germ cell cancer	0.000741	0.00473	CbGeAlD
Gefitinib—CSNK1E—female gonad—germ cell cancer	0.000731	0.00467	CbGeAlD
Gefitinib—ERBB3—spinal cord—germ cell cancer	0.000728	0.00465	CbGeAlD
Gefitinib—IRAK4—female gonad—germ cell cancer	0.000719	0.00459	CbGeAlD
Gefitinib—MKNK2—adrenal gland—germ cell cancer	0.000719	0.00459	CbGeAlD
Gefitinib—IRAK1—adrenal gland—germ cell cancer	0.000719	0.00459	CbGeAlD
Gefitinib—MAP2K5—telencephalon—germ cell cancer	0.000718	0.00458	CbGeAlD
Gefitinib—MKNK1—adrenal gland—germ cell cancer	0.00071	0.00453	CbGeAlD
Gefitinib—MKNK2—midbrain—germ cell cancer	0.00071	0.00453	CbGeAlD
Gefitinib—IRAK1—midbrain—germ cell cancer	0.00071	0.00453	CbGeAlD
Gefitinib—ERBB3—female gonad—germ cell cancer	0.000705	0.0045	CbGeAlD
Gefitinib—MKNK1—midbrain—germ cell cancer	0.000701	0.00448	CbGeAlD
Gefitinib—MKNK2—bone marrow—germ cell cancer	0.000696	0.00444	CbGeAlD
Gefitinib—IRAK1—bone marrow—germ cell cancer	0.000696	0.00444	CbGeAlD
Gefitinib—MKNK2—spinal cord—germ cell cancer	0.000693	0.00442	CbGeAlD
Gefitinib—EPHA6—brain—germ cell cancer	0.000688	0.00439	CbGeAlD
Gefitinib—MKNK1—bone marrow—germ cell cancer	0.000687	0.00439	CbGeAlD
Gefitinib—MKNK1—spinal cord—germ cell cancer	0.000684	0.00437	CbGeAlD
Gefitinib—MAP2K5—decidua—germ cell cancer	0.00068	0.00435	CbGeAlD
Gefitinib—CSNK1E—endocrine gland—germ cell cancer	0.00068	0.00434	CbGeAlD
Gefitinib—EGFR—testis—germ cell cancer	0.000674	0.0043	CbGeAlD
Gefitinib—CSNK1E—head—germ cell cancer	0.000671	0.00428	CbGeAlD
Gefitinib—STK10—gonad—germ cell cancer	0.000671	0.00428	CbGeAlD
Gefitinib—MKNK2—female gonad—germ cell cancer	0.000671	0.00428	CbGeAlD
Gefitinib—IRAK1—female gonad—germ cell cancer	0.000671	0.00428	CbGeAlD
Gefitinib—STK10—uterus—germ cell cancer	0.000666	0.00426	CbGeAlD
Gefitinib—Pneumonia—Dactinomycin—germ cell cancer	0.000663	0.00338	CcSEcCtD
Gefitinib—MKNK1—female gonad—germ cell cancer	0.000662	0.00423	CbGeAlD
Gefitinib—IRAK4—head—germ cell cancer	0.00066	0.00422	CbGeAlD
Gefitinib—ERBB3—endocrine gland—germ cell cancer	0.000656	0.00419	CbGeAlD
Gefitinib—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.000654	0.00334	CcSEcCtD
Gefitinib—CSNK1E—testis—germ cell cancer	0.000648	0.00414	CbGeAlD
Gefitinib—ERBB3—head—germ cell cancer	0.000647	0.00413	CbGeAlD
Gefitinib—Stomatitis—Dactinomycin—germ cell cancer	0.000643	0.00328	CcSEcCtD
Gefitinib—IRAK4—testis—germ cell cancer	0.000638	0.00407	CbGeAlD
Gefitinib—Haemoglobin—Bleomycin—germ cell cancer	0.000638	0.00325	CcSEcCtD
Gefitinib—Haemorrhage—Bleomycin—germ cell cancer	0.000635	0.00324	CcSEcCtD
Gefitinib—Dehydration—Cisplatin—germ cell cancer	0.000629	0.00321	CcSEcCtD
Gefitinib—ERBB3—testis—germ cell cancer	0.000625	0.00399	CbGeAlD
Gefitinib—MAP3K19—brain—germ cell cancer	0.000625	0.00399	CbGeAlD
Gefitinib—MKNK2—endocrine gland—germ cell cancer	0.000624	0.00398	CbGeAlD
Gefitinib—EGFR—cerebellum—germ cell cancer	0.000622	0.00398	CbGeAlD
Gefitinib—MKNK1—endocrine gland—germ cell cancer	0.000616	0.00393	CbGeAlD
Gefitinib—MKNK2—head—germ cell cancer	0.000616	0.00393	CbGeAlD
Gefitinib—Hypokalaemia—Cisplatin—germ cell cancer	0.000615	0.00314	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.000609	0.00311	CcSEcCtD
Gefitinib—MKNK1—head—germ cell cancer	0.000608	0.00388	CbGeAlD
Gefitinib—Pneumonia—Ifosfamide—germ cell cancer	0.000608	0.0031	CcSEcCtD
Gefitinib—Anaemia—Vinblastine—germ cell cancer	0.000605	0.00309	CcSEcCtD
Gefitinib—Infestation NOS—Ifosfamide—germ cell cancer	0.000604	0.00308	CcSEcCtD
Gefitinib—Infestation—Ifosfamide—germ cell cancer	0.000604	0.00308	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.000599	0.00306	CcSEcCtD
Gefitinib—CSNK1E—cerebellum—germ cell cancer	0.000599	0.00382	CbGeAlD
Gefitinib—MKNK2—testis—germ cell cancer	0.000595	0.0038	CbGeAlD
Gefitinib—IRAK1—testis—germ cell cancer	0.000595	0.0038	CbGeAlD
Gefitinib—Hepatitis—Dactinomycin—germ cell cancer	0.000592	0.00302	CcSEcCtD
Gefitinib—Malaise—Vinblastine—germ cell cancer	0.00059	0.00301	CcSEcCtD
Gefitinib—IRAK4—cerebellum—germ cell cancer	0.000589	0.00376	CbGeAlD
Gefitinib—Stomatitis—Ifosfamide—germ cell cancer	0.000589	0.00301	CcSEcCtD
Gefitinib—Conjunctivitis—Ifosfamide—germ cell cancer	0.000587	0.003	CcSEcCtD
Gefitinib—MKNK1—testis—germ cell cancer	0.000587	0.00375	CbGeAlD
Gefitinib—STK10—adrenal gland—germ cell cancer	0.000585	0.00373	CbGeAlD
Gefitinib—MAP2K5—pituitary gland—germ cell cancer	0.000584	0.00373	CbGeAlD
Gefitinib—Proteinuria—Methotrexate—germ cell cancer	0.000582	0.00297	CcSEcCtD
Gefitinib—ERBB3—cerebellum—germ cell cancer	0.000578	0.00369	CbGeAlD
Gefitinib—Haematuria—Ifosfamide—germ cell cancer	0.000576	0.00294	CcSEcCtD
Gefitinib—Protein urine present—Methotrexate—germ cell cancer	0.000574	0.00293	CcSEcCtD
Gefitinib—Pancreatitis—Cisplatin—germ cell cancer	0.000573	0.00292	CcSEcCtD
Gefitinib—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.000571	0.00292	CcSEcCtD
Gefitinib—STK10—bone marrow—germ cell cancer	0.000566	0.00361	CbGeAlD
Gefitinib—MAP2K5—medulla oblongata—germ cell cancer	0.000564	0.0036	CbGeAlD
Gefitinib—Alopecia—Bleomycin—germ cell cancer	0.000561	0.00286	CcSEcCtD
Gefitinib—Erythema multiforme—Dactinomycin—germ cell cancer	0.00056	0.00286	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000558	0.00285	CcSEcCtD
Gefitinib—IRAK1—cerebellum—germ cell cancer	0.000549	0.00351	CbGeAlD
Gefitinib—MKNK2—cerebellum—germ cell cancer	0.000549	0.00351	CbGeAlD
Gefitinib—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000546	0.00279	CcSEcCtD
Gefitinib—STK10—female gonad—germ cell cancer	0.000545	0.00348	CbGeAlD
Gefitinib—Haemoglobin—Ifosfamide—germ cell cancer	0.000545	0.00278	CcSEcCtD
Gefitinib—Haemorrhage—Ifosfamide—germ cell cancer	0.000542	0.00277	CcSEcCtD
Gefitinib—Hepatitis—Ifosfamide—germ cell cancer	0.000542	0.00277	CcSEcCtD
Gefitinib—MKNK1—cerebellum—germ cell cancer	0.000542	0.00346	CbGeAlD
Gefitinib—Ulcer—Methotrexate—germ cell cancer	0.00054	0.00276	CcSEcCtD
Gefitinib—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000536	0.00273	CcSEcCtD
Gefitinib—Urethral disorder—Ifosfamide—germ cell cancer	0.000532	0.00271	CcSEcCtD
Gefitinib—Alopecia—Dactinomycin—germ cell cancer	0.000523	0.00267	CcSEcCtD
Gefitinib—Thrombocytopenia—Vinblastine—germ cell cancer	0.000523	0.00267	CcSEcCtD
Gefitinib—MAP2K5—adrenal gland—germ cell cancer	0.000522	0.00333	CbGeAlD
Gefitinib—Respiratory failure—Methotrexate—germ cell cancer	0.00052	0.00266	CcSEcCtD
Gefitinib—MAP2K5—midbrain—germ cell cancer	0.000516	0.00329	CbGeAlD
Gefitinib—Erythema multiforme—Ifosfamide—germ cell cancer	0.000513	0.00262	CcSEcCtD
Gefitinib—Anaemia—Bleomycin—germ cell cancer	0.000511	0.00261	CcSEcCtD
Gefitinib—Anorexia—Vinblastine—germ cell cancer	0.000509	0.0026	CcSEcCtD
Gefitinib—Stomatitis—Cisplatin—germ cell cancer	0.000508	0.00259	CcSEcCtD
Gefitinib—STK10—endocrine gland—germ cell cancer	0.000507	0.00324	CbGeAlD
Gefitinib—Eye disorder—Ifosfamide—germ cell cancer	0.000507	0.00259	CcSEcCtD
Gefitinib—Conjunctivitis—Cisplatin—germ cell cancer	0.000506	0.00258	CcSEcCtD
Gefitinib—EGFR—brain—germ cell cancer	0.000506	0.00323	CbGeAlD
Gefitinib—Cardiac disorder—Ifosfamide—germ cell cancer	0.000503	0.00257	CcSEcCtD
Gefitinib—MAP2K5—spinal cord—germ cell cancer	0.000503	0.00321	CbGeAlD
Gefitinib—STK10—head—germ cell cancer	0.000501	0.0032	CbGeAlD
Gefitinib—Cystitis noninfective—Methotrexate—germ cell cancer	0.000499	0.00255	CcSEcCtD
Gefitinib—Melaena—Methotrexate—germ cell cancer	0.000499	0.00255	CcSEcCtD
Gefitinib—Malaise—Bleomycin—germ cell cancer	0.000498	0.00254	CcSEcCtD
Gefitinib—Cystitis—Methotrexate—germ cell cancer	0.000493	0.00252	CcSEcCtD
Gefitinib—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000493	0.00251	CcSEcCtD
Gefitinib—Angiopathy—Ifosfamide—germ cell cancer	0.000492	0.00251	CcSEcCtD
Gefitinib—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000489	0.00249	CcSEcCtD
Gefitinib—EGFR—lymph node—germ cell cancer	0.000489	0.00312	CbGeAlD
Gefitinib—MAP2K5—female gonad—germ cell cancer	0.000487	0.00311	CbGeAlD
Gefitinib—CSNK1E—brain—germ cell cancer	0.000486	0.0031	CbGeAlD
Gefitinib—Arrhythmia—Ifosfamide—germ cell cancer	0.000485	0.00247	CcSEcCtD
Gefitinib—STK10—testis—germ cell cancer	0.000484	0.00309	CbGeAlD
Gefitinib—Cough—Bleomycin—germ cell cancer	0.000482	0.00246	CcSEcCtD
Gefitinib—Pneumonia—Etoposide—germ cell cancer	0.00048	0.00245	CcSEcCtD
Gefitinib—Alopecia—Ifosfamide—germ cell cancer	0.000479	0.00245	CcSEcCtD
Gefitinib—IRAK4—brain—germ cell cancer	0.000479	0.00306	CbGeAlD
Gefitinib—Infestation NOS—Etoposide—germ cell cancer	0.000477	0.00244	CcSEcCtD
Gefitinib—Infestation—Etoposide—germ cell cancer	0.000477	0.00244	CcSEcCtD
Gefitinib—Anaemia—Dactinomycin—germ cell cancer	0.000476	0.00243	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000473	0.00241	CcSEcCtD
Gefitinib—Malnutrition—Ifosfamide—germ cell cancer	0.000472	0.00241	CcSEcCtD
Gefitinib—CSNK1E—lymph node—germ cell cancer	0.00047	0.003	CbGeAlD
Gefitinib—ERBB3—brain—germ cell cancer	0.000469	0.003	CbGeAlD
Gefitinib—Stomatitis—Etoposide—germ cell cancer	0.000465	0.00237	CcSEcCtD
Gefitinib—Malaise—Dactinomycin—germ cell cancer	0.000465	0.00237	CcSEcCtD
Gefitinib—Decreased appetite—Vinblastine—germ cell cancer	0.000464	0.00237	CcSEcCtD
Gefitinib—IRAK4—lymph node—germ cell cancer	0.000462	0.00295	CbGeAlD
Gefitinib—Mouth ulceration—Methotrexate—germ cell cancer	0.000462	0.00236	CcSEcCtD
Gefitinib—Bladder pain—Methotrexate—germ cell cancer	0.000462	0.00236	CcSEcCtD
Gefitinib—Urinary tract disorder—Cisplatin—germ cell cancer	0.000462	0.00236	CcSEcCtD
Gefitinib—Urethral disorder—Cisplatin—germ cell cancer	0.000458	0.00234	CcSEcCtD
Gefitinib—Pain—Vinblastine—germ cell cancer	0.000457	0.00233	CcSEcCtD
Gefitinib—Constipation—Vinblastine—germ cell cancer	0.000457	0.00233	CcSEcCtD
Gefitinib—ERBB3—lymph node—germ cell cancer	0.000453	0.00289	CbGeAlD
Gefitinib—MAP2K5—endocrine gland—germ cell cancer	0.000453	0.00289	CbGeAlD
Gefitinib—Hepatobiliary disease—Etoposide—germ cell cancer	0.000451	0.0023	CcSEcCtD
Gefitinib—Infection—Bleomycin—germ cell cancer	0.000448	0.00229	CcSEcCtD
Gefitinib—MAP2K5—head—germ cell cancer	0.000447	0.00285	CbGeAlD
Gefitinib—STK10—cerebellum—germ cell cancer	0.000447	0.00285	CbGeAlD
Gefitinib—MKNK2—brain—germ cell cancer	0.000446	0.00285	CbGeAlD
Gefitinib—IRAK1—brain—germ cell cancer	0.000446	0.00285	CbGeAlD
Gefitinib—ABCG2—trigeminal ganglion—germ cell cancer	0.000445	0.00284	CbGeAlD
Gefitinib—Thrombocytopenia—Bleomycin—germ cell cancer	0.000441	0.00225	CcSEcCtD
Gefitinib—MKNK1—brain—germ cell cancer	0.00044	0.00281	CbGeAlD
Gefitinib—Eye disorder—Cisplatin—germ cell cancer	0.000437	0.00223	CcSEcCtD
Gefitinib—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000437	0.00223	CcSEcCtD
Gefitinib—Anaemia—Ifosfamide—germ cell cancer	0.000436	0.00223	CcSEcCtD
Gefitinib—Cardiac disorder—Cisplatin—germ cell cancer	0.000434	0.00221	CcSEcCtD
Gefitinib—MAP2K5—testis—germ cell cancer	0.000432	0.00276	CbGeAlD
Gefitinib—Angioedema—Ifosfamide—germ cell cancer	0.000431	0.0022	CcSEcCtD
Gefitinib—MKNK2—lymph node—germ cell cancer	0.000431	0.00275	CbGeAlD
Gefitinib—IRAK1—lymph node—germ cell cancer	0.000431	0.00275	CbGeAlD
Gefitinib—Anorexia—Bleomycin—germ cell cancer	0.00043	0.00219	CcSEcCtD
Gefitinib—Thrombophlebitis—Methotrexate—germ cell cancer	0.000429	0.00219	CcSEcCtD
Gefitinib—Malaise—Ifosfamide—germ cell cancer	0.000426	0.00217	CcSEcCtD
Gefitinib—MKNK1—lymph node—germ cell cancer	0.000426	0.00272	CbGeAlD
Gefitinib—Urinary tract disorder—Etoposide—germ cell cancer	0.000423	0.00216	CcSEcCtD
Gefitinib—Abdominal pain—Vinblastine—germ cell cancer	0.000422	0.00215	CcSEcCtD
Gefitinib—Mediastinal disorder—Cisplatin—germ cell cancer	0.000421	0.00215	CcSEcCtD
Gefitinib—Hypotension—Bleomycin—germ cell cancer	0.000421	0.00215	CcSEcCtD
Gefitinib—Urethral disorder—Etoposide—germ cell cancer	0.00042	0.00214	CcSEcCtD
Gefitinib—Infection—Dactinomycin—germ cell cancer	0.000418	0.00213	CcSEcCtD
Gefitinib—Arrhythmia—Cisplatin—germ cell cancer	0.000418	0.00213	CcSEcCtD
Gefitinib—Alopecia—Cisplatin—germ cell cancer	0.000413	0.00211	CcSEcCtD
Gefitinib—Hepatic failure—Methotrexate—germ cell cancer	0.000413	0.00211	CcSEcCtD
Gefitinib—Cough—Ifosfamide—germ cell cancer	0.000412	0.0021	CcSEcCtD
Gefitinib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000412	0.0021	CcSEcCtD
Gefitinib—ORM1—bone marrow—germ cell cancer	0.00041	0.00262	CbGeAlD
Gefitinib—ORM1—spinal cord—germ cell cancer	0.000408	0.00261	CbGeAlD
Gefitinib—Malnutrition—Cisplatin—germ cell cancer	0.000407	0.00208	CcSEcCtD
Gefitinib—Erythema multiforme—Etoposide—germ cell cancer	0.000405	0.00207	CcSEcCtD
Gefitinib—Dyspnoea—Bleomycin—germ cell cancer	0.000402	0.00205	CcSEcCtD
Gefitinib—Anorexia—Dactinomycin—germ cell cancer	0.000401	0.00205	CcSEcCtD
Gefitinib—Eye disorder—Etoposide—germ cell cancer	0.0004	0.00204	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000399	0.00204	CcSEcCtD
Gefitinib—MAP2K5—cerebellum—germ cell cancer	0.000399	0.00255	CbGeAlD
Gefitinib—Cardiac disorder—Etoposide—germ cell cancer	0.000398	0.00203	CcSEcCtD
Gefitinib—Hypersensitivity—Vinblastine—germ cell cancer	0.000393	0.00201	CcSEcCtD
Gefitinib—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000393	0.00201	CcSEcCtD
Gefitinib—Decreased appetite—Bleomycin—germ cell cancer	0.000392	0.002	CcSEcCtD
Gefitinib—Angiopathy—Etoposide—germ cell cancer	0.000389	0.00198	CcSEcCtD
Gefitinib—Mediastinal disorder—Etoposide—germ cell cancer	0.000386	0.00197	CcSEcCtD
Gefitinib—Pain—Bleomycin—germ cell cancer	0.000386	0.00197	CcSEcCtD
Gefitinib—Asthenia—Vinblastine—germ cell cancer	0.000383	0.00195	CcSEcCtD
Gefitinib—Infection—Ifosfamide—germ cell cancer	0.000383	0.00195	CcSEcCtD
Gefitinib—Alopecia—Etoposide—germ cell cancer	0.000379	0.00193	CcSEcCtD
Gefitinib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000378	0.00193	CcSEcCtD
Gefitinib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000377	0.00193	CcSEcCtD
Gefitinib—Anaemia—Cisplatin—germ cell cancer	0.000376	0.00192	CcSEcCtD
Gefitinib—Skin disorder—Ifosfamide—germ cell cancer	0.000374	0.00191	CcSEcCtD
Gefitinib—ALB—adrenal gland—germ cell cancer	0.000372	0.00237	CbGeAlD
Gefitinib—ORM1—endocrine gland—germ cell cancer	0.000368	0.00235	CbGeAlD
Gefitinib—Anorexia—Ifosfamide—germ cell cancer	0.000367	0.00187	CcSEcCtD
Gefitinib—Malaise—Cisplatin—germ cell cancer	0.000367	0.00187	CcSEcCtD
Gefitinib—Decreased appetite—Dactinomycin—germ cell cancer	0.000366	0.00187	CcSEcCtD
Gefitinib—Diarrhoea—Vinblastine—germ cell cancer	0.000365	0.00186	CcSEcCtD
Gefitinib—STK10—brain—germ cell cancer	0.000363	0.00232	CbGeAlD
Gefitinib—Fatigue—Dactinomycin—germ cell cancer	0.000363	0.00185	CcSEcCtD
Gefitinib—Hypotension—Ifosfamide—germ cell cancer	0.00036	0.00184	CcSEcCtD
Gefitinib—Pain—Dactinomycin—germ cell cancer	0.00036	0.00183	CcSEcCtD
Gefitinib—Urticaria—Bleomycin—germ cell cancer	0.000358	0.00183	CcSEcCtD
Gefitinib—Body temperature increased—Bleomycin—germ cell cancer	0.000356	0.00182	CcSEcCtD
Gefitinib—ABCB1—blood vessel—germ cell cancer	0.000355	0.00227	CbGeAlD
Gefitinib—STK10—lymph node—germ cell cancer	0.00035	0.00224	CbGeAlD
Gefitinib—ABCG2—telencephalon—germ cell cancer	0.000349	0.00223	CbGeAlD
Gefitinib—Anaemia—Etoposide—germ cell cancer	0.000345	0.00176	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000344	0.00176	CcSEcCtD
Gefitinib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000344	0.00175	CcSEcCtD
Gefitinib—Dyspnoea—Ifosfamide—germ cell cancer	0.000344	0.00175	CcSEcCtD
Gefitinib—Vomiting—Vinblastine—germ cell cancer	0.000339	0.00173	CcSEcCtD
Gefitinib—Malaise—Etoposide—germ cell cancer	0.000336	0.00172	CcSEcCtD
Gefitinib—Decreased appetite—Ifosfamide—germ cell cancer	0.000335	0.00171	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000334	0.0017	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000333	0.0017	CcSEcCtD
Gefitinib—Abdominal pain—Dactinomycin—germ cell cancer	0.000332	0.0017	CcSEcCtD
Gefitinib—Body temperature increased—Dactinomycin—germ cell cancer	0.000332	0.0017	CcSEcCtD
Gefitinib—Fatigue—Ifosfamide—germ cell cancer	0.000332	0.0017	CcSEcCtD
Gefitinib—Hypersensitivity—Bleomycin—germ cell cancer	0.000332	0.0017	CcSEcCtD
Gefitinib—ABCG2—decidua—germ cell cancer	0.000331	0.00211	CbGeAlD
Gefitinib—Infection—Cisplatin—germ cell cancer	0.00033	0.00168	CcSEcCtD
Gefitinib—Pain—Ifosfamide—germ cell cancer	0.00033	0.00168	CcSEcCtD
Gefitinib—Constipation—Ifosfamide—germ cell cancer	0.00033	0.00168	CcSEcCtD
Gefitinib—Nervous system disorder—Cisplatin—germ cell cancer	0.000326	0.00166	CcSEcCtD
Gefitinib—Cough—Etoposide—germ cell cancer	0.000325	0.00166	CcSEcCtD
Gefitinib—Thrombocytopenia—Cisplatin—germ cell cancer	0.000325	0.00166	CcSEcCtD
Gefitinib—MAP2K5—brain—germ cell cancer	0.000324	0.00207	CbGeAlD
Gefitinib—Asthenia—Bleomycin—germ cell cancer	0.000324	0.00165	CcSEcCtD
Gefitinib—Skin disorder—Cisplatin—germ cell cancer	0.000323	0.00165	CcSEcCtD
Gefitinib—Pruritus—Bleomycin—germ cell cancer	0.000319	0.00163	CcSEcCtD
Gefitinib—Nausea—Vinblastine—germ cell cancer	0.000317	0.00162	CcSEcCtD
Gefitinib—Anorexia—Cisplatin—germ cell cancer	0.000317	0.00162	CcSEcCtD
Gefitinib—CYP1A1—skin of body—germ cell cancer	0.000316	0.00202	CbGeAlD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000315	0.00161	CcSEcCtD
Gefitinib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000315	0.00161	CcSEcCtD
Gefitinib—Pancreatitis—Methotrexate—germ cell cancer	0.000314	0.0016	CcSEcCtD
Gefitinib—MAP2K5—lymph node—germ cell cancer	0.000313	0.002	CbGeAlD
Gefitinib—Hypotension—Cisplatin—germ cell cancer	0.00031	0.00158	CcSEcCtD
Gefitinib—Hypersensitivity—Dactinomycin—germ cell cancer	0.00031	0.00158	CcSEcCtD
Gefitinib—ALB—testis—germ cell cancer	0.000307	0.00196	CbGeAlD
Gefitinib—Urticaria—Ifosfamide—germ cell cancer	0.000306	0.00156	CcSEcCtD
Gefitinib—Body temperature increased—Ifosfamide—germ cell cancer	0.000305	0.00155	CcSEcCtD
Gefitinib—Abdominal pain—Ifosfamide—germ cell cancer	0.000305	0.00155	CcSEcCtD
Gefitinib—Infection—Etoposide—germ cell cancer	0.000302	0.00154	CcSEcCtD
Gefitinib—Asthenia—Dactinomycin—germ cell cancer	0.000302	0.00154	CcSEcCtD
Gefitinib—Thrombocytopenia—Etoposide—germ cell cancer	0.000298	0.00152	CcSEcCtD
Gefitinib—Dyspnoea—Cisplatin—germ cell cancer	0.000296	0.00151	CcSEcCtD
Gefitinib—Skin disorder—Etoposide—germ cell cancer	0.000296	0.00151	CcSEcCtD
Gefitinib—Anorexia—Etoposide—germ cell cancer	0.00029	0.00148	CcSEcCtD
Gefitinib—ABCG2—uterus—germ cell cancer	0.00029	0.00185	CbGeAlD
Gefitinib—Decreased appetite—Cisplatin—germ cell cancer	0.000289	0.00147	CcSEcCtD
Gefitinib—Diarrhoea—Dactinomycin—germ cell cancer	0.000288	0.00147	CcSEcCtD
Gefitinib—Pneumonia—Methotrexate—germ cell cancer	0.000288	0.00147	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000287	0.00146	CcSEcCtD
Gefitinib—Vomiting—Bleomycin—germ cell cancer	0.000287	0.00146	CcSEcCtD
Gefitinib—Infestation NOS—Methotrexate—germ cell cancer	0.000286	0.00146	CcSEcCtD
Gefitinib—Infestation—Methotrexate—germ cell cancer	0.000286	0.00146	CcSEcCtD
Gefitinib—Hypotension—Etoposide—germ cell cancer	0.000284	0.00145	CcSEcCtD
Gefitinib—ABCG2—pituitary gland—germ cell cancer	0.000284	0.00182	CbGeAlD
Gefitinib—Rash—Bleomycin—germ cell cancer	0.000284	0.00145	CcSEcCtD
Gefitinib—Pain—Cisplatin—germ cell cancer	0.000284	0.00145	CcSEcCtD
Gefitinib—Dermatitis—Bleomycin—germ cell cancer	0.000284	0.00145	CcSEcCtD
Gefitinib—Hypersensitivity—Ifosfamide—germ cell cancer	0.000284	0.00145	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000283	0.00145	CcSEcCtD
Gefitinib—Stomatitis—Methotrexate—germ cell cancer	0.000279	0.00142	CcSEcCtD
Gefitinib—Conjunctivitis—Methotrexate—germ cell cancer	0.000278	0.00142	CcSEcCtD
Gefitinib—Asthenia—Ifosfamide—germ cell cancer	0.000276	0.00141	CcSEcCtD
Gefitinib—CYP1A1—uterus—germ cell cancer	0.000275	0.00176	CbGeAlD
Gefitinib—ABCG2—medulla oblongata—germ cell cancer	0.000274	0.00175	CbGeAlD
Gefitinib—Pruritus—Ifosfamide—germ cell cancer	0.000273	0.00139	CcSEcCtD
Gefitinib—Haematuria—Methotrexate—germ cell cancer	0.000273	0.00139	CcSEcCtD
Gefitinib—Dyspnoea—Etoposide—germ cell cancer	0.000271	0.00138	CcSEcCtD
Gefitinib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00027	0.00138	CcSEcCtD
Gefitinib—CYP2D6—brainstem—germ cell cancer	0.00027	0.00172	CbGeAlD
Gefitinib—Epistaxis—Methotrexate—germ cell cancer	0.00027	0.00138	CcSEcCtD
Gefitinib—Nausea—Bleomycin—germ cell cancer	0.000268	0.00137	CcSEcCtD
Gefitinib—Vomiting—Dactinomycin—germ cell cancer	0.000267	0.00136	CcSEcCtD
Gefitinib—Rash—Dactinomycin—germ cell cancer	0.000265	0.00135	CcSEcCtD
Gefitinib—Decreased appetite—Etoposide—germ cell cancer	0.000265	0.00135	CcSEcCtD
Gefitinib—Diarrhoea—Ifosfamide—germ cell cancer	0.000264	0.00135	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000263	0.00134	CcSEcCtD
Gefitinib—Body temperature increased—Cisplatin—germ cell cancer	0.000263	0.00134	CcSEcCtD
Gefitinib—Fatigue—Etoposide—germ cell cancer	0.000262	0.00134	CcSEcCtD
Gefitinib—Constipation—Etoposide—germ cell cancer	0.00026	0.00133	CcSEcCtD
Gefitinib—Pain—Etoposide—germ cell cancer	0.00026	0.00133	CcSEcCtD
Gefitinib—CYP2C19—endocrine gland—germ cell cancer	0.00026	0.00166	CbGeAlD
Gefitinib—Haemoglobin—Methotrexate—germ cell cancer	0.000258	0.00132	CcSEcCtD
Gefitinib—Hepatitis—Methotrexate—germ cell cancer	0.000257	0.00131	CcSEcCtD
Gefitinib—Haemorrhage—Methotrexate—germ cell cancer	0.000257	0.00131	CcSEcCtD
Gefitinib—ORM1—lymph node—germ cell cancer	0.000254	0.00162	CbGeAlD
Gefitinib—ABCG2—adrenal gland—germ cell cancer	0.000254	0.00162	CbGeAlD
Gefitinib—Urinary tract disorder—Methotrexate—germ cell cancer	0.000253	0.00129	CcSEcCtD
Gefitinib—Urethral disorder—Methotrexate—germ cell cancer	0.000252	0.00128	CcSEcCtD
Gefitinib—ABCG2—midbrain—germ cell cancer	0.000251	0.0016	CbGeAlD
Gefitinib—Nausea—Dactinomycin—germ cell cancer	0.00025	0.00127	CcSEcCtD
Gefitinib—Gastrointestinal pain—Etoposide—germ cell cancer	0.000249	0.00127	CcSEcCtD
Gefitinib—ABCG2—bone marrow—germ cell cancer	0.000246	0.00157	CbGeAlD
Gefitinib—Vomiting—Ifosfamide—germ cell cancer	0.000245	0.00125	CcSEcCtD
Gefitinib—Hypersensitivity—Cisplatin—germ cell cancer	0.000245	0.00125	CcSEcCtD
Gefitinib—ABCG2—spinal cord—germ cell cancer	0.000245	0.00156	CbGeAlD
Gefitinib—Rash—Ifosfamide—germ cell cancer	0.000243	0.00124	CcSEcCtD
Gefitinib—Dermatitis—Ifosfamide—germ cell cancer	0.000243	0.00124	CcSEcCtD
Gefitinib—Erythema multiforme—Methotrexate—germ cell cancer	0.000243	0.00124	CcSEcCtD
Gefitinib—Urticaria—Etoposide—germ cell cancer	0.000242	0.00123	CcSEcCtD
Gefitinib—Body temperature increased—Etoposide—germ cell cancer	0.000241	0.00123	CcSEcCtD
Gefitinib—Abdominal pain—Etoposide—germ cell cancer	0.000241	0.00123	CcSEcCtD
Gefitinib—Eye disorder—Methotrexate—germ cell cancer	0.00024	0.00122	CcSEcCtD
Gefitinib—CYP2D6—telencephalon—germ cell cancer	0.000239	0.00153	CbGeAlD
Gefitinib—Asthenia—Cisplatin—germ cell cancer	0.000238	0.00122	CcSEcCtD
Gefitinib—Cardiac disorder—Methotrexate—germ cell cancer	0.000238	0.00122	CcSEcCtD
Gefitinib—ABCG2—female gonad—germ cell cancer	0.000237	0.00151	CbGeAlD
Gefitinib—Angiopathy—Methotrexate—germ cell cancer	0.000233	0.00119	CcSEcCtD
Gefitinib—Mediastinal disorder—Methotrexate—germ cell cancer	0.000231	0.00118	CcSEcCtD
Gefitinib—ALB—brain—germ cell cancer	0.000231	0.00147	CbGeAlD
Gefitinib—Nausea—Ifosfamide—germ cell cancer	0.000229	0.00117	CcSEcCtD
Gefitinib—Diarrhoea—Cisplatin—germ cell cancer	0.000227	0.00116	CcSEcCtD
Gefitinib—Alopecia—Methotrexate—germ cell cancer	0.000227	0.00116	CcSEcCtD
Gefitinib—CYP1A1—female gonad—germ cell cancer	0.000225	0.00144	CbGeAlD
Gefitinib—Hypersensitivity—Etoposide—germ cell cancer	0.000224	0.00114	CcSEcCtD
Gefitinib—Malnutrition—Methotrexate—germ cell cancer	0.000223	0.00114	CcSEcCtD
Gefitinib—ALB—lymph node—germ cell cancer	0.000223	0.00142	CbGeAlD
Gefitinib—CYP3A5—female gonad—germ cell cancer	0.00022	0.0014	CbGeAlD
Gefitinib—ABCB1—trigeminal ganglion—germ cell cancer	0.000219	0.0014	CbGeAlD
Gefitinib—Asthenia—Etoposide—germ cell cancer	0.000218	0.00111	CcSEcCtD
Gefitinib—Pruritus—Etoposide—germ cell cancer	0.000215	0.0011	CcSEcCtD
Gefitinib—ABCB1—embryo—germ cell cancer	0.000212	0.00135	CbGeAlD
Gefitinib—Vomiting—Cisplatin—germ cell cancer	0.000211	0.00108	CcSEcCtD
Gefitinib—ABCG2—testis—germ cell cancer	0.00021	0.00134	CbGeAlD
Gefitinib—Rash—Cisplatin—germ cell cancer	0.000209	0.00107	CcSEcCtD
Gefitinib—Dermatitis—Cisplatin—germ cell cancer	0.000209	0.00107	CcSEcCtD
Gefitinib—CYP1A1—endocrine gland—germ cell cancer	0.000209	0.00134	CbGeAlD
Gefitinib—Diarrhoea—Etoposide—germ cell cancer	0.000208	0.00106	CcSEcCtD
Gefitinib—Anaemia—Methotrexate—germ cell cancer	0.000206	0.00105	CcSEcCtD
Gefitinib—CYP1A1—head—germ cell cancer	0.000206	0.00132	CbGeAlD
Gefitinib—CYP3A5—endocrine gland—germ cell cancer	0.000204	0.00131	CbGeAlD
Gefitinib—Malaise—Methotrexate—germ cell cancer	0.000201	0.00103	CcSEcCtD
Gefitinib—CYP2C9—endocrine gland—germ cell cancer	0.000201	0.00129	CbGeAlD
Gefitinib—Nausea—Cisplatin—germ cell cancer	0.000197	0.00101	CcSEcCtD
Gefitinib—Cough—Methotrexate—germ cell cancer	0.000195	0.000995	CcSEcCtD
Gefitinib—ABCG2—cerebellum—germ cell cancer	0.000194	0.00124	CbGeAlD
Gefitinib—Vomiting—Etoposide—germ cell cancer	0.000194	0.000987	CcSEcCtD
Gefitinib—Rash—Etoposide—germ cell cancer	0.000192	0.000979	CcSEcCtD
Gefitinib—Dermatitis—Etoposide—germ cell cancer	0.000192	0.000978	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000189	0.000964	CcSEcCtD
Gefitinib—ABCB1—retina—germ cell cancer	0.000187	0.0012	CbGeAlD
Gefitinib—Infection—Methotrexate—germ cell cancer	0.000181	0.000924	CcSEcCtD
Gefitinib—Nausea—Etoposide—germ cell cancer	0.000181	0.000922	CcSEcCtD
Gefitinib—Nervous system disorder—Methotrexate—germ cell cancer	0.000179	0.000912	CcSEcCtD
Gefitinib—Thrombocytopenia—Methotrexate—germ cell cancer	0.000179	0.000911	CcSEcCtD
Gefitinib—Skin disorder—Methotrexate—germ cell cancer	0.000177	0.000904	CcSEcCtD
Gefitinib—Anorexia—Methotrexate—germ cell cancer	0.000174	0.000887	CcSEcCtD
Gefitinib—ABCB1—telencephalon—germ cell cancer	0.000172	0.0011	CbGeAlD
Gefitinib—Hypotension—Methotrexate—germ cell cancer	0.00017	0.000869	CcSEcCtD
Gefitinib—ABCB1—decidua—germ cell cancer	0.000163	0.00104	CbGeAlD
Gefitinib—Dyspnoea—Methotrexate—germ cell cancer	0.000163	0.000829	CcSEcCtD
Gefitinib—CYP2D6—female gonad—germ cell cancer	0.000162	0.00104	CbGeAlD
Gefitinib—Decreased appetite—Methotrexate—germ cell cancer	0.000158	0.000809	CcSEcCtD
Gefitinib—ABCG2—brain—germ cell cancer	0.000158	0.00101	CbGeAlD
Gefitinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000157	0.000803	CcSEcCtD
Gefitinib—Fatigue—Methotrexate—germ cell cancer	0.000157	0.000802	CcSEcCtD
Gefitinib—Pain—Methotrexate—germ cell cancer	0.000156	0.000795	CcSEcCtD
Gefitinib—CYP3A4—endocrine gland—germ cell cancer	0.000153	0.00098	CbGeAlD
Gefitinib—ABCG2—lymph node—germ cell cancer	0.000152	0.000972	CbGeAlD
Gefitinib—CYP2D6—endocrine gland—germ cell cancer	0.000151	0.000964	CbGeAlD
Gefitinib—CYP1A1—brain—germ cell cancer	0.00015	0.000955	CbGeAlD
Gefitinib—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000149	0.000761	CcSEcCtD
Gefitinib—CYP2D6—head—germ cell cancer	0.000149	0.000952	CbGeAlD
Gefitinib—Urticaria—Methotrexate—germ cell cancer	0.000145	0.000739	CcSEcCtD
Gefitinib—CYP1A1—lymph node—germ cell cancer	0.000145	0.000923	CbGeAlD
Gefitinib—Body temperature increased—Methotrexate—germ cell cancer	0.000144	0.000735	CcSEcCtD
Gefitinib—Abdominal pain—Methotrexate—germ cell cancer	0.000144	0.000735	CcSEcCtD
Gefitinib—CYP2D6—testis—germ cell cancer	0.000144	0.00092	CbGeAlD
Gefitinib—ABCB1—gonad—germ cell cancer	0.000144	0.000918	CbGeAlD
Gefitinib—ABCB1—uterus—germ cell cancer	0.000143	0.000912	CbGeAlD
Gefitinib—ABCB1—pituitary gland—germ cell cancer	0.00014	0.000895	CbGeAlD
Gefitinib—ABCB1—medulla oblongata—germ cell cancer	0.000135	0.000864	CbGeAlD
Gefitinib—Hypersensitivity—Methotrexate—germ cell cancer	0.000134	0.000685	CcSEcCtD
Gefitinib—CYP2D6—cerebellum—germ cell cancer	0.000133	0.000849	CbGeAlD
Gefitinib—Asthenia—Methotrexate—germ cell cancer	0.000131	0.000667	CcSEcCtD
Gefitinib—Pruritus—Methotrexate—germ cell cancer	0.000129	0.000658	CcSEcCtD
Gefitinib—ABCB1—adrenal gland—germ cell cancer	0.000125	0.0008	CbGeAlD
Gefitinib—Diarrhoea—Methotrexate—germ cell cancer	0.000125	0.000636	CcSEcCtD
Gefitinib—ABCB1—midbrain—germ cell cancer	0.000124	0.00079	CbGeAlD
Gefitinib—ABCB1—bone marrow—germ cell cancer	0.000121	0.000774	CbGeAlD
Gefitinib—ABCB1—spinal cord—germ cell cancer	0.000121	0.000771	CbGeAlD
Gefitinib—ABCB1—female gonad—germ cell cancer	0.000117	0.000746	CbGeAlD
Gefitinib—Vomiting—Methotrexate—germ cell cancer	0.000116	0.000591	CcSEcCtD
Gefitinib—Rash—Methotrexate—germ cell cancer	0.000115	0.000587	CcSEcCtD
Gefitinib—Dermatitis—Methotrexate—germ cell cancer	0.000115	0.000586	CcSEcCtD
Gefitinib—ABCB1—endocrine gland—germ cell cancer	0.000109	0.000694	CbGeAlD
Gefitinib—Nausea—Methotrexate—germ cell cancer	0.000108	0.000553	CcSEcCtD
Gefitinib—CYP2D6—brain—germ cell cancer	0.000108	0.00069	CbGeAlD
Gefitinib—ABCB1—head—germ cell cancer	0.000107	0.000685	CbGeAlD
Gefitinib—ABCB1—testis—germ cell cancer	0.000104	0.000662	CbGeAlD
Gefitinib—ABCB1—cerebellum—germ cell cancer	9.57e-05	0.000611	CbGeAlD
Gefitinib—EGFR—B Cell Activation—KIT—germ cell cancer	8.5e-05	0.000711	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—FGF4—germ cell cancer	8.35e-05	0.000699	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	8.22e-05	0.000688	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling of activated FGFR—HRAS—germ cell cancer	8.18e-05	0.000684	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	8.13e-05	0.00068	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—FGF4—germ cell cancer	8.07e-05	0.000675	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—TP53—germ cell cancer	8.06e-05	0.000674	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB4—HRAS—germ cell cancer	8.05e-05	0.000673	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—KIT—germ cell cancer	8.04e-05	0.000672	CbGpPWpGaD
Gefitinib—MAP2K5—Insulin Signaling—HRAS—germ cell cancer	8.02e-05	0.000671	CbGpPWpGaD
Gefitinib—MAP2K5—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	7.94e-05	0.000664	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—KITLG—germ cell cancer	7.82e-05	0.000654	CbGpPWpGaD
Gefitinib—ABCB1—brain—germ cell cancer	7.77e-05	0.000496	CbGeAlD
Gefitinib—ERBB3—Downstream signal transduction—HRAS—germ cell cancer	7.69e-05	0.000643	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—TP53—germ cell cancer	7.68e-05	0.000642	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR—HRAS—germ cell cancer	7.65e-05	0.00064	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB2—HRAS—germ cell cancer	7.61e-05	0.000637	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 signaling—HRAS—germ cell cancer	7.58e-05	0.000634	CbGpPWpGaD
Gefitinib—ABCB1—lymph node—germ cell cancer	7.51e-05	0.00048	CbGeAlD
Gefitinib—CSNK1E—Signaling by Wnt—MYC—germ cell cancer	7.47e-05	0.000625	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	7.47e-05	0.000625	CbGpPWpGaD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	7.37e-05	0.000616	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—HRAS—germ cell cancer	7.34e-05	0.000614	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—FGF4—germ cell cancer	7.26e-05	0.000608	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—H2AFZ—germ cell cancer	7.2e-05	0.000603	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	7.13e-05	0.000596	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 interactions—HRAS—germ cell cancer	7.13e-05	0.000596	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR in disease—HRAS—germ cell cancer	7.13e-05	0.000596	CbGpPWpGaD
Gefitinib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	7.12e-05	0.000596	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR—HRAS—germ cell cancer	7.06e-05	0.000591	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR in Cancer—HRAS—germ cell cancer	7e-05	0.000586	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—MYC—germ cell cancer	6.99e-05	0.000585	CbGpPWpGaD
Gefitinib—MAP2K5—Focal Adhesion—HRAS—germ cell cancer	6.99e-05	0.000584	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—FGFR3—germ cell cancer	6.98e-05	0.000584	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by PDGF—HRAS—germ cell cancer	6.97e-05	0.000583	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—CD9—germ cell cancer	6.88e-05	0.000576	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—KITLG—germ cell cancer	6.86e-05	0.000574	CbGpPWpGaD
Gefitinib—EPHA6—Axon guidance—HRAS—germ cell cancer	6.84e-05	0.000572	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—FGFR3—germ cell cancer	6.81e-05	0.00057	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—FGFR3—germ cell cancer	6.7e-05	0.000561	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—FGF4—germ cell cancer	6.66e-05	0.000557	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—KITLG—germ cell cancer	6.63e-05	0.000554	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—OXT—germ cell cancer	6.62e-05	0.000554	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—HRAS—germ cell cancer	6.6e-05	0.000552	CbGpPWpGaD
Gefitinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	6.55e-05	0.000548	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—H2AFZ—germ cell cancer	6.49e-05	0.000543	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—KIT—germ cell cancer	6.41e-05	0.000536	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—FGF4—germ cell cancer	6.36e-05	0.000532	CbGpPWpGaD
Gefitinib—MKNK1—Disease—FGFR3—germ cell cancer	6.33e-05	0.00053	CbGpPWpGaD
Gefitinib—ERBB3—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	6.31e-05	0.000528	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—KIT—germ cell cancer	6.25e-05	0.000523	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—HRAS—germ cell cancer	6.19e-05	0.000518	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—KIT—germ cell cancer	6.15e-05	0.000515	CbGpPWpGaD
Gefitinib—ERBB3—Disease—FGF4—germ cell cancer	6.15e-05	0.000514	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.14e-05	0.000513	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—FGF4—germ cell cancer	6.11e-05	0.000511	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.05e-05	0.000506	CbGpPWpGaD
Gefitinib—EGFR—ErbB1 downstream signaling—HRAS—germ cell cancer	6.03e-05	0.000504	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—KITLG—germ cell cancer	5.97e-05	0.000499	CbGpPWpGaD
Gefitinib—EGFR—Disease—SLC2A3—germ cell cancer	5.96e-05	0.000498	CbGpPWpGaD
Gefitinib—EGFR—Immune System—PVRL2—germ cell cancer	5.87e-05	0.000491	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—AVP—germ cell cancer	5.83e-05	0.000488	CbGpPWpGaD
Gefitinib—MKNK1—Disease—KIT—germ cell cancer	5.82e-05	0.000486	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—FGFR3—germ cell cancer	5.81e-05	0.000486	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—TP53—germ cell cancer	5.74e-05	0.00048	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	5.74e-05	0.00048	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.69e-05	0.000476	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—MYC—germ cell cancer	5.66e-05	0.000473	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—FGF4—germ cell cancer	5.65e-05	0.000473	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.57e-05	0.000466	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—FGF4—germ cell cancer	5.54e-05	0.000464	CbGpPWpGaD
Gefitinib—ERBB3—Disease—H2AFZ—germ cell cancer	5.49e-05	0.000459	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—KITLG—germ cell cancer	5.47e-05	0.000458	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle, Mitotic—MYC—germ cell cancer	5.43e-05	0.000454	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.38e-05	0.00045	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—KIT—germ cell cancer	5.34e-05	0.000446	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.3e-05	0.000443	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—MYC—germ cell cancer	5.27e-05	0.000441	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TP53—germ cell cancer	5.26e-05	0.00044	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—OXT—germ cell cancer	5.23e-05	0.000438	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—KITLG—germ cell cancer	5.23e-05	0.000437	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.18e-05	0.000434	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—FGFR3—germ cell cancer	5.1e-05	0.000427	CbGpPWpGaD
Gefitinib—ERBB3—Disease—KITLG—germ cell cancer	5.05e-05	0.000422	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—H2AFZ—germ cell cancer	5.05e-05	0.000422	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—OXT—germ cell cancer	5.04e-05	0.000422	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—HRAS—germ cell cancer	5.04e-05	0.000421	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—KITLG—germ cell cancer	5.02e-05	0.00042	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—TP53—germ cell cancer	5.01e-05	0.000419	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—FGFR3—germ cell cancer	4.93e-05	0.000412	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—HRAS—germ cell cancer	4.88e-05	0.000408	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—HRAS—germ cell cancer	4.86e-05	0.000406	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—MYC—germ cell cancer	4.85e-05	0.000406	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—HRAS—germ cell cancer	4.76e-05	0.000398	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.75e-05	0.000398	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—OXT—germ cell cancer	4.75e-05	0.000398	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	4.71e-05	0.000394	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—KIT—germ cell cancer	4.68e-05	0.000392	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SLC2A3—germ cell cancer	4.66e-05	0.00039	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.65e-05	0.000389	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—TP53—germ cell cancer	4.65e-05	0.000389	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—KITLG—germ cell cancer	4.64e-05	0.000388	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SLC22A3—germ cell cancer	4.59e-05	0.000384	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	4.59e-05	0.000384	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—HRAS—germ cell cancer	4.55e-05	0.000381	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—KITLG—germ cell cancer	4.55e-05	0.000381	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AVP—germ cell cancer	4.54e-05	0.000379	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—KIT—germ cell cancer	4.52e-05	0.000378	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—HRAS—germ cell cancer	4.48e-05	0.000375	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—FGF4—germ cell cancer	4.47e-05	0.000374	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—FGFR3—germ cell cancer	4.44e-05	0.000371	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TP53—germ cell cancer	4.33e-05	0.000362	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—FGF4—germ cell cancer	4.3e-05	0.00036	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—HRAS—germ cell cancer	4.28e-05	0.000358	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—HRAS—germ cell cancer	4.26e-05	0.000356	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	4.26e-05	0.000356	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.24e-05	0.000355	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—HRAS—germ cell cancer	4.24e-05	0.000355	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—HRAS—germ cell cancer	4.22e-05	0.000353	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—OXT—germ cell cancer	4.2e-05	0.000351	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	4.16e-05	0.000348	CbGpPWpGaD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—HRAS—germ cell cancer	4.11e-05	0.000344	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—KIT—germ cell cancer	4.07e-05	0.000341	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—FGFR3—germ cell cancer	4.07e-05	0.00034	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—HRAS—germ cell cancer	4.04e-05	0.000338	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—H2AFZ—germ cell cancer	3.99e-05	0.000334	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—TP53—germ cell cancer	3.98e-05	0.000333	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	3.97e-05	0.000332	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—HRAS—germ cell cancer	3.97e-05	0.000332	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—HRAS—germ cell cancer	3.97e-05	0.000332	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—HRAS—germ cell cancer	3.93e-05	0.000329	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.9e-05	0.000327	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—HRAS—germ cell cancer	3.9e-05	0.000326	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—FGFR3—germ cell cancer	3.89e-05	0.000325	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—HRAS—germ cell cancer	3.88e-05	0.000325	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—H2AFZ—germ cell cancer	3.84e-05	0.000322	CbGpPWpGaD
Gefitinib—ERBB3—Disease—FGFR3—germ cell cancer	3.75e-05	0.000314	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—HRAS—germ cell cancer	3.75e-05	0.000314	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CRABP1—germ cell cancer	3.74e-05	0.000313	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—KIT—germ cell cancer	3.73e-05	0.000312	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—FGFR3—germ cell cancer	3.73e-05	0.000312	CbGpPWpGaD
Gefitinib—EGFR—Immune System—FGF4—germ cell cancer	3.71e-05	0.00031	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—HRAS—germ cell cancer	3.67e-05	0.000307	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—KITLG—germ cell cancer	3.67e-05	0.000307	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AVP—germ cell cancer	3.59e-05	0.0003	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—FGF4—germ cell cancer	3.58e-05	0.0003	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—KIT—germ cell cancer	3.57e-05	0.000298	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—KITLG—germ cell cancer	3.54e-05	0.000296	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	3.51e-05	0.000294	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—HRAS—germ cell cancer	3.47e-05	0.000291	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AVP—germ cell cancer	3.46e-05	0.000289	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—FGFR3—germ cell cancer	3.45e-05	0.000289	CbGpPWpGaD
Gefitinib—ERBB3—Disease—KIT—germ cell cancer	3.45e-05	0.000288	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—KIT—germ cell cancer	3.43e-05	0.000287	CbGpPWpGaD
Gefitinib—EGFR—Disease—FGF4—germ cell cancer	3.42e-05	0.000286	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	3.4e-05	0.000284	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—FGFR3—germ cell cancer	3.38e-05	0.000283	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SLC2A3—germ cell cancer	3.34e-05	0.000279	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SLC22A3—germ cell cancer	3.29e-05	0.000275	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AVP—germ cell cancer	3.26e-05	0.000272	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—H2AFZ—germ cell cancer	3.2e-05	0.000268	CbGpPWpGaD
Gefitinib—MKNK1—Disease—MYC—germ cell cancer	3.2e-05	0.000268	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—KIT—germ cell cancer	3.17e-05	0.000265	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SLC2A3—germ cell cancer	3.15e-05	0.000264	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—KIT—germ cell cancer	3.11e-05	0.00026	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SLC22A3—germ cell cancer	3.11e-05	0.00026	CbGpPWpGaD
Gefitinib—EGFR—Disease—H2AFZ—germ cell cancer	3.06e-05	0.000256	CbGpPWpGaD
Gefitinib—EGFR—Immune System—KITLG—germ cell cancer	3.05e-05	0.000255	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—KITLG—germ cell cancer	2.94e-05	0.000246	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AVP—germ cell cancer	2.88e-05	0.000241	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC2A3—germ cell cancer	2.87e-05	0.00024	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC22A3—germ cell cancer	2.83e-05	0.000237	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	2.83e-05	0.000237	CbGpPWpGaD
Gefitinib—EGFR—Disease—KITLG—germ cell cancer	2.81e-05	0.000235	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—OXT—germ cell cancer	2.81e-05	0.000235	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—HRAS—germ cell cancer	2.77e-05	0.000232	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—FGFR3—germ cell cancer	2.73e-05	0.000228	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—HRAS—germ cell cancer	2.7e-05	0.000226	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CRABP1—germ cell cancer	2.68e-05	0.000224	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—HRAS—germ cell cancer	2.66e-05	0.000222	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—FGFR3—germ cell cancer	2.63e-05	0.00022	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC2A3—germ cell cancer	2.58e-05	0.000216	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC22A3—germ cell cancer	2.54e-05	0.000213	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CRABP1—germ cell cancer	2.53e-05	0.000212	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC2A3—germ cell cancer	2.52e-05	0.000211	CbGpPWpGaD
Gefitinib—MKNK1—Disease—HRAS—germ cell cancer	2.51e-05	0.00021	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—KIT—germ cell cancer	2.5e-05	0.000209	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—MYC—germ cell cancer	2.49e-05	0.000208	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC22A3—germ cell cancer	2.48e-05	0.000208	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.48e-05	0.000207	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—HRAS—germ cell cancer	2.45e-05	0.000205	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—KIT—germ cell cancer	2.41e-05	0.000202	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.4e-05	0.000201	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—FGF4—germ cell cancer	2.4e-05	0.0002	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC2A3—germ cell cancer	2.37e-05	0.000199	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC2A3—germ cell cancer	2.35e-05	0.000197	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC22A3—germ cell cancer	2.34e-05	0.000196	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC22A3—germ cell cancer	2.32e-05	0.000194	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CRABP1—germ cell cancer	2.31e-05	0.000193	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—HRAS—germ cell cancer	2.31e-05	0.000193	CbGpPWpGaD
Gefitinib—EGFR—Immune System—FGFR3—germ cell cancer	2.26e-05	0.000189	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MYC—germ cell cancer	2.24e-05	0.000187	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—FGFR3—germ cell cancer	2.19e-05	0.000183	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—H2AFZ—germ cell cancer	2.14e-05	0.000179	CbGpPWpGaD
Gefitinib—EGFR—Disease—FGFR3—germ cell cancer	2.09e-05	0.000175	CbGpPWpGaD
Gefitinib—EGFR—Immune System—KIT—germ cell cancer	2.08e-05	0.000174	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CRABP1—germ cell cancer	2.07e-05	0.000173	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—HRAS—germ cell cancer	2.02e-05	0.000169	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CRABP1—germ cell cancer	2.02e-05	0.000169	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—KIT—germ cell cancer	2.01e-05	0.000168	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.97e-05	0.000165	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KITLG—germ cell cancer	1.97e-05	0.000165	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—HRAS—germ cell cancer	1.95e-05	0.000163	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AVP—germ cell cancer	1.92e-05	0.000161	CbGpPWpGaD
Gefitinib—EGFR—Disease—KIT—germ cell cancer	1.92e-05	0.00016	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.91e-05	0.000159	CbGpPWpGaD
Gefitinib—ERBB3—Disease—MYC—germ cell cancer	1.9e-05	0.000159	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CRABP1—germ cell cancer	1.89e-05	0.000158	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—germ cell cancer	1.84e-05	0.000154	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HRAS—germ cell cancer	1.76e-05	0.000147	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—HRAS—germ cell cancer	1.75e-05	0.000146	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MYC—germ cell cancer	1.74e-05	0.000146	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—HRAS—germ cell cancer	1.61e-05	0.000135	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.55e-05	0.00013	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—HRAS—germ cell cancer	1.54e-05	0.000129	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.53e-05	0.000128	CbGpPWpGaD
Gefitinib—ERBB3—Disease—HRAS—germ cell cancer	1.49e-05	0.000125	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—HRAS—germ cell cancer	1.48e-05	0.000124	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—FGFR3—germ cell cancer	1.46e-05	0.000122	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—germ cell cancer	1.43e-05	0.00012	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MYC—germ cell cancer	1.38e-05	0.000115	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HRAS—germ cell cancer	1.37e-05	0.000114	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—KIT—germ cell cancer	1.34e-05	0.000112	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—HRAS—germ cell cancer	1.34e-05	0.000112	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MYC—germ cell cancer	1.33e-05	0.000111	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.25e-05	0.000104	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—germ cell cancer	1.13e-05	9.46e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MYC—germ cell cancer	1.11e-05	9.25e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—germ cell cancer	1.09e-05	9.12e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HRAS—germ cell cancer	1.08e-05	9.05e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—MYC—germ cell cancer	1.06e-05	8.83e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HRAS—germ cell cancer	1.04e-05	8.72e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—germ cell cancer	1.03e-05	8.63e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—HRAS—germ cell cancer	9.87e-06	8.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HRAS—germ cell cancer	9.83e-06	8.22e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—germ cell cancer	9.08e-06	7.59e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HRAS—germ cell cancer	8.98e-06	7.51e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HRAS—germ cell cancer	8.68e-06	7.26e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—HRAS—germ cell cancer	8.29e-06	6.94e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MYC—germ cell cancer	7.39e-06	6.18e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—germ cell cancer	6.07e-06	5.08e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HRAS—germ cell cancer	5.81e-06	4.86e-05	CbGpPWpGaD
